56.3 F
New York
Tuesday, May 17, 2022

Clene [NASDAQ: CLNN] Gets Two Patent Notice of Allowances

Must read

Clene Inc. [NASDAQ: CLNN] disclosed that Clene Nanomedicine, Inc. U.S. Patent and Trademark Office has provided Notices of Allowance for two significant patent applications. Clene Nanomedicine is the subsidiary of CNN. Additionally, the notices include device and process entitled for its platform technology and sophisticated stage clean-surfaced nanocrystal therapeutic candidates.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .

Sponsored

The first allowed application named “Continuous Methods for Treating Liquids and Manufacturing Certain Constituents in Liquids, Apparatuses, and Nanoparticles and Nanoparticle/Liquid Solution(s) Resulting Therefrom”. It includes a vast range of device privileges related to electrochemical technology platforms for CLNN for making solutions and suspensions.

Furthermore, it has been disclosed that both patents, once granted, will continue to offer important intellectual property protection for CNM-Au8. CNM-Au8 is the top drug candidate of Clene. CNM-Au8 is now being assessed across seven clinical studies for the cure of amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and Parkinson’s disease.

Additionally, the global patent portfolio in the new field of clean-surfaced nanocrystal therapeutics of Clene now covers over 130 patents. These patents are granted and allowed. Moreover, it has been disclosed that nearly 30 more applications are still waiting.

Additionally, the granted patents include state of matter claims for suspensions and solutions, as well as processes for making the materials, devices for overseeing the unique electro-crystal chemistry processes, and methods of using the novel materials.

More articles

Latest article